TrLink GMP Modified Nucleoside Triphosphates

Last updated: 24th April, 2023

TriLink has introduced the first GMP-grade Modified Nucleoside Triphosphates available, N1-Methylpseudouridine-5’-Triphosphate.

This modified nucleoside is chemically synthesized and ready to scale into your mRNA therapeutics production needs.

Premier Materials for mRNA Therapies
Backed by 25+ years of experience, TriLink’s industry-leading high-purity modified nucleoside triphosphates (NTPs) optimize and enhance mRNA performance to promote robust expression. Their extensive portfolio includes the most-requested modified NTPs, readily available and custom made to order.

Explore and learn about TriLink modified NTP

Download Brochure >

Request a Quote

Request Quote

Go BackGo Back